These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6178499)

  • 1. Carcinoma of type II pneumocytes. PAS staining as a screening test for nuclear inclusions of surfactant specific apoprotein.
    Singh G; Katyal SL; Torikata C
    Cancer; 1982 Sep; 50(5):946-8. PubMed ID: 6178499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type II pneumocytes in pulmonary tumors. Implications for histogenesis.
    Singh G; Katyal SL; Ordonez NG; Dail DH; Negishi Y; Weedn VW; Marcus PB; Weldon-Linne CM; Axiotis CA; Alvarez-Fernandez E
    Arch Pathol Lab Med; 1984 Jan; 108(1):44-8. PubMed ID: 6318684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistological analysis of surfactant-apoprotein in the bronchiolo-alveolar carcinoma.
    Dairaku M; Sueishi K; Tanaka K; Horie A
    Virchows Arch A Pathol Anat Histopathol; 1983; 400(3):223-34. PubMed ID: 6310856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathobiologic features of carcinomas of type II pneumocytes. An immunocytologic study.
    Singh G; Scheithauer BW; Katyal SL
    Cancer; 1986 Mar; 57(5):994-9. PubMed ID: 2417691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma of type II pneumocytes: immunodiagnosis of a subtype of "bronchioloalveolar carcinomas".
    Singh G; Katyal SL; Torikata C
    Am J Pathol; 1981 Feb; 102(2):195-208. PubMed ID: 6258440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity of surfactant-apoprotein in adenocarcinomas, large cell and small cell carcinomas of the lung.
    Kitinya JN; Sueishi K; Tanaka K; Katsuda Y
    Acta Pathol Jpn; 1986 Sep; 36(9):1271-8. PubMed ID: 3024446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of lung adenocarcinoma using monoclonal antibody for 60-kilodalton antigen in type II pneumocytes and nonciliated bronchiolar epithelial cells. Comparison with two antisurfactant apoprotein antibodies.
    Suehiro T; Maeda K; Sueishi K
    Am J Clin Pathol; 1989 Aug; 92(2):150-8. PubMed ID: 2547307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant apoprotein in nonmalignant pulmonary disorders.
    Singh G; Katyal SL
    Am J Pathol; 1980 Oct; 101(1):51-61. PubMed ID: 7004201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors. Special reference to nonmucus producing lung adenocarcinomas.
    Mizutani Y; Nakajima T; Morinaga S; Gotoh M; Shimosato Y; Akino T; Suzuki A
    Cancer; 1988 Feb; 61(3):532-7. PubMed ID: 3338020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical studies on the expression of pulmonary surfactant apoproteins in human lung carcinomas using monoclonal antibodies.
    Dempo K; Satoh M; Tsuji S; Mori M; Kuroki Y; Akino T
    Pathol Res Pract; 1987 Oct; 182(5):669-75. PubMed ID: 2825147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.
    Zamecnik J; Kodet R
    Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bronchiolo-alveolar carcinoma]. Histologic analysis of 3 cases, one of which with ultrastructural study].
    Linoli O; Ventura P
    Pathologica; 1994 Oct; 86(5):513-24. PubMed ID: 7739877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD208/dendritic cell-lysosomal associated membrane protein is a marker of normal and transformed type II pneumocytes.
    Salaun B; de Saint-Vis B; Pacheco N; Pacheco Y; Riesler A; Isaac S; Leroux C; Clair-Moninot V; Pin JJ; Griffith J; Treilleux I; Goddard S; Davoust J; Kleijmeer M; Lebecque S
    Am J Pathol; 2004 Mar; 164(3):861-71. PubMed ID: 14982840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerosing hemangioma of the lung. An epithelial tumor composed of immunohistochemically heterogenous cells.
    Nagata N; Dairaku M; Sueishi K; Tanaka K
    Am J Clin Pathol; 1987 Nov; 88(5):552-9. PubMed ID: 2823596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alveolar adenoma of the lung. Immunohistochemical characterization of type II pneumocytes].
    Köppl H; Freudenberg N; Berwanger I; Frenzer K; Böhm N
    Pathologe; 1996 Mar; 17(2):150-3. PubMed ID: 8650145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchiolo-alveolar carcinoma with nuclear tubular inclusions. Case report and electron microscopy findings.
    Matoska J; Bayer A; Dianovsky D
    Zentralbl Allg Pathol; 1986; 131(4):371-8. PubMed ID: 3014785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytomorphologic criteria of bronchioloalveolar cell cancer].
    de Masi D; Atay Z
    Pneumologie; 1990 Feb; 44 Suppl 1():610-1. PubMed ID: 2164208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates.
    Clayton F
    Cancer; 1986 Apr; 57(8):1555-64. PubMed ID: 3004694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origin of bronchioloalveolar carcinoma and peripheral bronchial adenocarcinoma.
    Dermer GB
    Cancer; 1982 Mar; 49(5):881-7. PubMed ID: 6277455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.